Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, bre... Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer and glioblastoma. We are driven by innovative science to develop novel and transformative drug therapies to treat cancer. In June 2021, Kairos acquired Enviro Therapeutics through a share exchange. The acquisition allowed us to incorporate into our company Enviros advanced pipeline of drug candidates in Phase 1 and Phase 2 trials. The pipeline includes two therapeutic agents addressing what we believe to be significant unmet needs in the prostate and lung cancer markets and that we believe can help address cancer progression in those cancers that develop resistance to standard therapies. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.047 | -4.84536082474 | 0.97 | 1.05 | 0.8844 | 75614 | 0.96275693 | CS |
| 4 | 0.0012 | 0.130180082447 | 0.9218 | 1.25 | 0.88 | 137614 | 1.01075698 | CS |
| 12 | -0.657 | -41.582278481 | 1.58 | 1.92 | 0.8506 | 396883 | 1.52858658 | CS |
| 26 | -0.567 | -38.0536912752 | 1.49 | 3.25 | 0.8506 | 1307733 | 2.00506319 | CS |
| 52 | -3.077 | -76.925 | 4 | 4 | 0.8506 | 1135688 | 2.00327996 | CS |
| 156 | -3.077 | -76.925 | 4 | 4 | 0.8506 | 1135688 | 2.00327996 | CS |
| 260 | -3.077 | -76.925 | 4 | 4 | 0.8506 | 1135688 | 2.00327996 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 9,20 (-1,50%) | 233,66M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 7,7151 (-0,06%) | 83,19M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 3,66 (0,14%) | 78,84M |
| SPYSPDR S&P 500 | US$ 526,41 (0,14%) | 78,53M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,57 (6,09%) | 69,9M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
